Corient Private Wealth’s MiMedx Group MDXG Stock Holding History

Corient Private Wealth’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.5K	Sell	21,643 -48,344	-69%	-$244K	﹤0.01%	2713
2025 Q4	$474K	Buy	69,987 +32,943	+89%	+$231K	﹤0.01%	2350
2025 Q3	$259K	Sell	37,044 -37,956	-51%	-$264K	﹤0.01%	2210
2025 Q2	$458K	Buy	75,000 +37,500	+100%	+$249K	﹤0.01%	1749
2025 Q1	$285K	Hold	37,500	–	–	﹤0.01%	1883
2024 Q4	$361K	Hold	37,500	–	–	﹤0.01%	1798
2024 Q3	$222K	Buy	37,500 +5,420	+17%	+$35.9K	﹤0.01%	2178
2024 Q2	$222K	Hold	32,080	–	–	﹤0.01%	2075
2024 Q1	$247K	Buy	32,080 +2,080	+7%	+$16.7K	﹤0.01%	1994
2023 Q4	$263K	Hold	30,000	–	–	﹤0.01%	1931
2023 Q3	$219K	Hold	30,000	–	–	﹤0.01%	1879
2023 Q2	$198K	Sell	30,000 -37,481	-56%	-$191K	﹤0.01%	1880
2023 Q1	$230K	Buy	+67,481	New	+$261K	﹤0.01%	1733

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Corient Private Wealth's MDXG Position: Q1 2026 in Review

Corient Private Wealth reduced its MiMedx Group (MDXG) stake by 69% in Q1 2026, selling an estimated $244K and leaving 21,643 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Corient Private Wealth first reported a position in MDXG in Q1 2023 and has held it in 13 quarters since. The position peaked at $474K in Q4 2025. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

Corient Private Wealth held 21,643 shares of MiMedx Group worth $85.5K as of Q1 2026.
Corient Private Wealth sold 48,344 MiMedx Group shares in Q1 2026, an estimated $244K.
MiMedx Group made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2713 holding.
Corient Private Wealth first reported a position in MiMedx Group in Q1 2023 and has held it in 13 quarters since.
Corient Private Wealth's MiMedx Group position peaked at $474K in Q4 2025.
237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.